Enhanced genome editing to ameliorate a genetic metabolic liver disease through co-delivery of adeno-associated virus receptor
Autor: | Chen Xi, Shuming Yin, Zhang Mei, Hongquan Geng, Yongguo Yu, Liren Wang, Shichang Li, Lie Ma, Yaqiang Hu, Mingyao Liu, Wenjuan Qiu, Yuting Guan, Weishi Yu, Honghui Han, Nan Shen, Dali Li, Shao Tingting |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
DNA Complementary Phenylalanine hydroxylase Genetic enhancement Genetic Vectors Biology medicine.disease_cause General Biochemistry Genetics and Molecular Biology Mice 03 medical and health sciences Transduction (genetics) 0302 clinical medicine Genome editing In vivo Phenylketonurias Complementary DNA medicine Animals Adeno-associated virus General Environmental Science Gene Editing Liver Diseases Phenylalanine Hydroxylase Dependovirus Molecular biology Disease Models Animal 030104 developmental biology 030220 oncology & carcinogenesis biology.protein General Agricultural and Biological Sciences Homologous recombination |
Zdroj: | Science China Life Sciences. 65:718-730 |
ISSN: | 1869-1889 1674-7305 |
DOI: | 10.1007/s11427-020-1744-6 |
Popis: | Genome editing through adeno-associated viral (AAV) vectors is a promising gene therapy strategy for various diseases, especially genetic disorders. However, homologous recombination (HR) efficiency is extremely low in adult animal models. We assumed that increasing AAV transduction efficiency could increase genome editing activity, especially HR efficiency, for in vivo gene therapy. Firstly, a mouse phenylketonuria (PKU) model carrying a pathogenic R408W mutation in phenylalanine hydroxylase (Pah) was generated. Through co-delivery of the general AAV receptor (AAVR), we found that AAVR could dramatically increase AAV transduction efficiency in vitro and in vivo. Furthermore, co-delivery of SaCas9/sgRNA/donor templates with AAVR via AAV8 vectors increased indel rate over 2-fold and HR rate over 15-fold for the correction of the single mutation in PahR408W mice. Moreover, AAVR co-injection successfully increased the site-specific insertion rate of a 1.4 kb Pah cDNA by 11-fold, bringing the HR rate up to 7.3% without detectable global off-target effects. Insertion of Pah cDNA significantly decreased the Phe level and ameliorated PKU symptoms. This study demonstrates a novel strategy to dramatically increase AAV transduction which substantially enhanced in vivo genome editing efficiency in adult animal models, showing clinical potential for both conventional and genome editing-based gene therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |